Dr. Thomas K. Rosvanis

Quoc-Dien Trinh, MD, MBA, serves as the Chair of the Department of Urology, University of Pittsburgh School of Medicine, and Chair of Urology, UPMC. A globally recognized urological surgeon-scientist, Dr. Trinh has been honored with the 2021 Outstanding Citizenship Award from Brigham and Women’s Hospital and the 2022 American Urological Association Young Urologist of the Year award for New England. He is recognized as a Castle Connolly Top Doctor and a Top Asian American Pacific Islander Doctor. Dr. Trinh is rated as an Elite provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy.

Goutham Vemana is an Urologist in Canonsburg, Pennsylvania. Dr. Vemana is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Familial Wilms Tumor 2, Ureteroscopy, and Nephrectomy.

Dr. Maranchie is a surgical oncologist specializing in urologic cancers of the urinary tract and male genitalia.  She completed urology residency at Harvard University in 1999, followed by a fellowship in Urologic Oncology at the National Cancer Institute.  Her practice is focused on the care of patients with cancer of the kidney, bladder and testis, employing minimally invasive approaches, nephron-sparing and nerve-sparing surgery and urinary tract reconstruction.  She has specialty expertise in familial or inherited cancer syndromes, offering targeted surveillance with organ-preserving surgery when indicated. LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. Dr. Maranchie is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy.